Kamada (KMDA) Return on Equity [ROE] (2013 - 2026)
Kamada (KMDA) recorded Return on Equity [ROE] of 8.41% in the quarter ended Jun 30, 2026, up 0.99 percentage points from 7.43% a year earlier and up 0.71 percentage points from the prior quarter.
Powered by 
Analysis
Kamada (KMDA) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Kamada reported Return on Equity [ROE] of 7.64%, up 1.90 percentage points from the prior year.
- Annual Return on Equity [ROE] has increased for three straight years, though with a five-year change of -3.28 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, Return on Equity [ROE] came in at 5.74% in the year ended Dec 31, 2024 (+1.80 pp), 3.94% in the year ended Dec 31, 2023 (+5.26 pp), -1.32% in the year ended Dec 31, 2022 (-0.06 pp) and -1.25% in the year ended Dec 31, 2021 (-12.17 pp).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Return on Equity [ROE] since the quarter ended Dec 31, 2020.
- On a year-over-year basis, Return on Equity [ROE] has increased for 14 consecutive quarters, with an average year-over-year change of +1.75 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 15.19 percentage points in the quarter ended Jun 30, 2023, against a drop of 19.89 percentage points in the quarter ended Jun 30, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 7.71% (quarter ended Mar 31, 2026), 7.56% (quarter ended Dec 31, 2025) and 7.79% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Kamada | 488.02 Mn | 197.08 Mn | 22.47 Mn | 8.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.41% |
| Mar 31, 2026 | 7.71% |
| Dec 31, 2025 | 7.56% |
| Sep 30, 2025 | 7.79% |
| Jun 30, 2025 | 7.43% |
| Mar 31, 2025 | 6.28% |
| Dec 31, 2024 | 5.62% |
| Sep 30, 2024 | 6.21% |
| Jun 30, 2024 | 6.00% |
| Mar 31, 2024 | 5.03% |
| Dec 31, 2023 | 3.43% |
| Sep 30, 2023 | 2.97% |
| Jun 30, 2023 | 1.95% |
| Mar 31, 2023 | -1.31% |
| Dec 31, 2022 | -1.33% |
| Sep 30, 2022 | -11.90% |
| Jun 30, 2022 | -13.24% |
| Mar 31, 2022 | -3.83% |
| Dec 31, 2021 | -1.24% |
| Sep 30, 2021 | 2.42% |
API Access
Kamada Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();